| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | trifluoperazine | CTRPv2 | pan-cancer | AAC | 0.12 | 0.002 |
| mRNA | CAY10618 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.002 |
| mRNA | Topotecan | CTRPv2 | pan-cancer | AAC | 0.095 | 0.002 |
| mRNA | KHS101 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.002 |
| mRNA | WZ3105 | GDSC1000 | pan-cancer | AAC | 0.087 | 0.002 |
| mRNA | SCH-529074 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.003 |
| mRNA | UNC0638 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.003 |
| mRNA | GW-2580 | GDSC1000 | pan-cancer | AAC | 0.1 | 0.003 |
| mRNA | BRD-K97651142 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.003 |
| mRNA | PD-0325901 | gCSI | pan-cancer | AAC | -0.15 | 0.003 |